• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Tejnaksh Share Price

    Tejnaksh Healthcare Share PriceTejnaksh Healthcare

    Small Cap 2.5k Result
    ₹31.33
    -0.6 (-1.88%)
    As on 29 November, 2023 | 00:43 BSE: 539428 NSE: TEJNAKSHISIN: INE030T01027
    Split

    Tejnaksh Healthcare Performance

    Day Range

    • Low
    • High
    31.33

    52 Week Range

    • Low
    • High
    31.33
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Tejnaksh Healthcare

    Start SIP

    Tejnaksh Healthcare Share Price

    • Over 1 Month 4.5%
    • Over 3 Month -8.87%
    • Over 6 Month -10.54%
    • Over 1 Year -45.84%

    Tejnaksh Healthcare Key Statistics

    Tejnaksh Healthcare Investment Rating

    • Master Rating:

    • Tejnaksh Healthcare has an operating revenue of Rs. 11.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 21% is great, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Tejnaksh Healthcare Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 2222222
    Operating Expenses Qtr Cr 1111111
    Operating Profit Qtr Cr 1101111
    Depreciation Qtr Cr 0000000
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 0000110
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 88
    Operating Expenses Annual Cr 44
    Operating Profit Annual in Cr 34
    Depreciation Cr 11
    Interest Annual Cr 10
    Tax Annual Cr 11
    Net Profit Annual Cr 13
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 29
    Cash from Investing Activity Annual Cr -1-10
    Cash from Financing Annual Activity Cr -12
    Net Cash Flow Annual Cr 00
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2120
    Fixed Assets Annual Cr 2323
    Total Non Current Assets Annual Cr 2525
    Total Current Assets Annual Cr 54
    Total Assets Annual Cr 3029
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 2119
    ROE Annual % 713
    ROCE Annual % 914
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 4655
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 3333433
    Operating Expenses Qtr Cr 2322222
    Operating Profit Qtr Cr 1101211
    Depreciation Qtr Cr 0000000
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 1000111
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1213
    Operating Expenses Annual Cr 88
    Operating Profit Annual in Cr 45
    Depreciation Cr 11
    Interest Annual Cr 10
    Tax Annual Cr 11
    Net Profit Annual Cr 23
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 29
    Cash from Investing Activity Annual Cr -1-11
    Cash from Financing Annual Activity Cr -12
    Net Cash Flow Annual Cr 00
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2220
    Fixed Assets Annual Cr 2121
    Total Non Current Assets Annual Cr 2525
    Total Current Assets Annual Cr 65
    Total Assets Annual Cr 3130
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 2220
    ROE Annual % 814
    ROCE Annual % 1115
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3439
    Invest in Tejnaksh Healthcare

    Tejnaksh Healthcare Technicals

    EMA & SMA

    Current Price
    ₹31.33
    -0.6 (-1.88%)
    pointer
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • ₹31.68
    • 50 Day
    • ₹31.95
    • 100 Day
    • ₹33.35
    • 200 Day
    • ₹37.99
    • 20 Day
    • ₹31.42
    • 50 Day
    • ₹31.74
    • 100 Day
    • ₹33.02
    • 200 Day
    • ₹36.01

    Tejnaksh Healthcare Resistance and Support

    PIVOT
    ₹31.98
    Resistance
    First Resistance ₹33.01
    Second Resistance ₹34.68
    Third Resistance ₹35.71
    RSI 47.64
    MFI 56.3
    MACD Single Line 0.15
    MACD 0.15
    Support
    First Resistance ₹30.31
    Second Resistance ₹29.28
    Third Resistance ₹27.61

    Tejnaksh Healthcare Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 58,361 4,214,248 72.21
    Week 34,387 2,880,964 83.78
    1 Month 38,608 3,135,340 81.21
    6 Month 42,164 2,893,693 68.63

    Tejnaksh Healthcare Result Highlights

    Tejnaksh Healthcare Synopsis

    BSE-Medical-Hospitals

    Tejnaksh Healthcare is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 7.34 Cr. and Equity Capital is Rs. 10.16 Cr. for the Year ended 31/03/2023. Tejnaksh Healthcare Ltd. is a Public Limited Listed company incorporated on 18/02/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85100MH2008PLC179034 and registration number is 179034.
    Market Cap 63
    Sales 7
    Shares in Float 0.53
    No of funds 1
    Yield
    Book Value 3
    U/D Vol ratio
    LTDebt / Equity 28
    Alpha -0.3
    Beta 1.65

    Tejnaksh Healthcare

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 73.83%73.83%73.83%73.83%
    Foreign Portfolio Investors 0.58%0.58%0.58%
    Individual Investors 23%22.74%22.72%23.83%
    Others 2.59%2.85%2.87%2.34%

    Tejnaksh Healthcare Management

    Name Designation
    Dr. Ashish Vishwas Rawandale Chairperson & Executive Director
    Dr.(Ms.) Preeti Ashish Rawandale Non Exe.Non Ind.Director
    Mr. Kiran Madhavrao Pawar Ind. Non-Executive Director
    Mr. Vikramsinh Satish Khatal Patil Ind. Non-Executive Director
    Mr. Suhas Thorat Ind. Non-Executive Director
    Mr. Sanjay Bhikajirao Khatal Non Exe.Non Ind.Director

    Tejnaksh Healthcare Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Tejnaksh Healthcare Corporate Action

    Date Purpose Remarks
    2023-11-11 Quarterly Results
    2023-08-12 Quarterly Results
    2023-05-20 Audited Results & Stock Split
    2023-02-11 Quarterly Results & Stock Split
    2022-11-07 Quarterly Results
    Date Purpose Remarks
    2023-07-19 Split Rs.0.00 split from Rs. 10/- to Rs. 5/-.

    Tejnaksh Healthcare FAQs

    What is Share Price of Tejnaksh Healthcare ?

    Tejnaksh Healthcare share price is ₹31 As on 29 November, 2023 | 00:29

    What is the Market Cap of Tejnaksh Healthcare ?

    The Market Cap of Tejnaksh Healthcare is ₹63.6 Cr As on 29 November, 2023 | 00:29

    What is the P/E ratio of Tejnaksh Healthcare ?

    The P/E ratio of Tejnaksh Healthcare is 62.3 As on 29 November, 2023 | 00:29

    What is the PB ratio of Tejnaksh Healthcare ?

    The PB ratio of Tejnaksh Healthcare is 2.8 As on 29 November, 2023 | 00:29

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.